Celcuity

Celcuity EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celcuity (CELC) as of Sep 26, 2026 is -172.19 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -113.27 M USD — a change of 52.02% (lower).

EBITDA

-172.19 MUSD

YoY

52.02%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celcuity is 2026 -172.19 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celcuity was 2025 -113.27 M USD. It decreases by 52.02% lower compared to the previous year.

The Celcuity EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-7.93 M USD
Jan 1, 2019
-7.81 M USD
Jan 1, 2020
-9.56 M USD
Jan 1, 2021
-28.36 M USD
Jan 1, 2022
-39.39 M USD
Jan 1, 2023
-66.23 M USD
Jan 1, 2024
-113.27 M USD
Jan 1, 2025
-172.19 M USD
The Celcuity EBITDA history
YEAREBITDAYoY
-172.19 MUSD+52.02%
-113.27 MUSD+71.02%
-66.23 MUSD+68.14%
-39.39 MUSD+38.92%
-28.36 MUSD+196.73%
-9.56 MUSD+22.43%
-7.81 MUSD-1.60%
-7.93 MUSD+33.25%
-5.95 MUSD+78.85%
-3.33 MUSD+47.16%
-2.26 MUSD—
Access this data via the Eulerpool API

Celcuity Stock analysis

What does Celcuity do? Celcuity Inc is a biotechnology company founded by Brian Sullivan in 2012. The company is headquartered in Minneapolis, USA. The business model of Celcuity is based on researching and developing new diagnostic and treatment methods for various types of cancer. The company utilizes a proprietary technology platform called CELx, which enables the analysis of cancer cell signaling pathways and the development of individualized treatment strategies. Celcuity specializes in the development of diagnostics and personalized therapies based on individual cancer cell signaling pathways. The company operates in two divisions: 1. Diagnostics division: Celcuity's diagnostics division focuses on identifying new cancer markers and biomarkers for early detection of cancer and the development of individualized treatment strategies. 2. Therapy division: Celcuity's therapy division specializes in the development of personalized therapies based on individual cancer cell signaling pathways. Celcuity currently offers two products based on the CELx technology platform: 1. CELx HUB: CELx HUB is a cloud-based software that allows doctors and researchers to analyze cancer samples and develop individualized treatment strategies. 2. CELx TIL: CELx TIL is a diagnostic tool that measures the presence of tumor cells in the immune system of cancer patients. In summary, Celcuity Inc is a leader in the field of personalized cancer therapy based on individual cancer cell signaling pathways. The company has found a niche in this growing market and has a unique technology platform that allows it to serve its customers effectively. With its products and services, Celcuity is helping to revolutionize cancer treatment and improve the quality of life for cancer patients worldwide. Celcuity is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celcuity stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celcuity is -172.19 M USD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Celcuity changed from -113.27 M USD to -172.19 M USD, representing a 52.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Celcuity since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Celcuity historically and in real time.

Access this data via the Eulerpool API

Income Statement — Celcuity

All Key Metrics — Celcuity